[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 1965

Carcinoma of the LungResults of Supervoltage Radiation Therapy

Author Affiliations

From the departments of radiology and medicine, Hahnemann Medical College. Fellow in Radiation Therapy, National Institutes of Health (Dr. Faust); Markle Scholar in Medical Science (Dr. Cander).

Arch Surg. 1965;90(1):90-94. doi:10.1001/archsurg.1965.01320070092020

IN THE MANAGEMENT of carcinoma of the lung, the most effective means for cure is probably surgical resection. However, the proportion of patients eligible for curative resection is relatively small. Garland2 reports that only about 20% of those with symptoms and about 40% of those without symptoms are eligible for curative surgery. Certainly no patient should be denied the opportunity for definitive surgery with extended resection of the involved lobe and the involved regional lymph nodes, when indicated.

Best results are to be anticipated if an experienced clinical team should carefully evaluate each patient with carcinoma of the lung. Emphasis should be placed on the resectability of the lesion, the ability of the patient to withstand the procedure, and the predictability of postoperative complications. In spite of great care in the selection of patients for operation, the total five-year survival rates with surgery alone are frustratingly poor, being variously

First Page Preview View Large
First page PDF preview
First page PDF preview